Rheumatoid Arthritis
- Boot Camp

- Oct 13, 2023
- 0 min read
History Taking
Chief Complaint
Persistent joint pain
Swelling in multiple joints
Morning stiffness lasting more than 1 hour
History of Presenting Complaint
Symmetrical joint involvement
Progressive worsening of symptoms over weeks to months
Exacerbation of symptoms with rest and improvement with activity
Fatigue and generalized weakness
System Review
Musculoskeletal: Joint deformities, limited joint range of motion
Constitutional: Unexplained weight loss, fever
Respiratory: Shortness of breath, dry cough (indicating possible interstitial lung disease)
Cardiovascular: Chest pain, palpitations (suggesting pericarditis, endocarditis)
Ocular: Dry eyes, pain, redness (indicating Sjögren's syndrome or episcleritis)
Skin: Rheumatoid nodules, vasculitic rash
Neurological: Numbness or tingling in extremities (indicating possible peripheral neuropathy)
Past Medical History
History of autoimmune disorders
Chronic infections, such as periodontitis
Non-specific symptoms which can indicate prodromal RA: fatigue, generalized weakness, anorexia, and weight loss
Past Surgical History
Previous orthopedic surgery related to joint damage or deformity
Drug History
Previous or current use of disease-modifying anti-rheumatic drugs (DMARDs), nonsteroidal anti-inflammatory drugs (NSAIDs), or corticosteroids
Response or lack of response to these treatments
Family History
Relatives with rheumatoid arthritis or other autoimmune disorders
Personal History
Smoking: A significant risk factor for RA
High body mass index: Obesity is a risk factor
Social History
Occupational history: Jobs involving repetitive joint use
Alcohol consumption: Some studies suggest moderate alcohol consumption may have a protective effect against RA
Physical Examination
General Examination
Pallor (due to chronic disease anemia)
Low-grade fever (reflecting systemic inflammation)
Rheumatoid nodules: Subcutaneous nodules often found on extensor surfaces such as the elbows
Hands and Arms Examination
Swollen joints with symmetrical involvement
Tenderness on palpation of the metacarpophalangeal and proximal interphalangeal joints
Ulnar deviation of the fingers
Z deformity in the thumb
Boutonnière deformity (flexion of proximal interphalangeal joint and hyperextension of distal interphalangeal joint)
Swan neck deformity (hyperextension of proximal interphalangeal joint and flexion of distal interphalangeal joint)
Rheumatoid nodules may be present on the extensor surfaces of the forearm
Mouth Examination
Dry mouth could be indicative of secondary Sjögren's syndrome
Neck Examination
Limited range of motion of the cervical spine due to atlanto-axial subluxation (though this is a late feature)
Cardiovascular Examination
Signs of pericarditis or endocarditis if relevant: muffled heart sounds, pericardial rub, new murmur
Respiratory Examination
Signs of pleural effusion or interstitial lung disease if relevant: reduced chest expansion, dullness to percussion, decreased breath sounds
Abdominal Examination
Splenomegaly for Felty’s syndrome
Investigations
Laboratory Investigations
Full Blood Count: To identify anemia of chronic disease, thrombocytosis
ESR and CRP: To assess level of inflammation, these markers are usually elevated in active disease
Rheumatoid Factor (RF): Positive in about 70-80% of patients with RA, though not specific
Anti-Cyclic Citrullinated Peptide (anti-CCP) Antibodies: High specificity for RA, may predict severe disease
Uric acid: To rule out gout
Liver Function Tests and Kidney Function Tests: Baseline before starting DMARDs; some of these medications can affect liver and kidney function
Antinuclear Antibodies (ANA): To rule out other autoimmune diseases like SLE
Imaging
X-rays of affected joints: To assess for joint erosions, joint space narrowing, periarticular osteopenia
Ultrasound of joints: To visualize synovitis, joint effusions, bony erosions
MRI: Can detect early erosive changes and synovitis before visible on x-ray
Invasive Investigations
Synovial fluid analysis: If joint effusion present, to rule out infection or crystal arthropathy
Other Investigations
Pulmonary function tests: If there is suspicion of interstitial lung disease
Echocardiogram: If cardiac involvement such as pericarditis or endocarditis is suspected.
Management
General Management
Patient education: Understanding the chronic nature of disease, importance of adherence to therapy
Physiotherapy: To maintain joint mobility and muscle strength
Occupational therapy: To provide assistive devices and strategies to minimize joint stress during daily activities
Regular exercise: To improve strength and flexibility, reduce pain
Smoking cessation: To reduce disease progression and comorbidity risk
Medical Management
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): For relief of acute symptoms
Glucocorticoids: Short-term use for acute flare-ups or as a bridge until DMARDs take effect
Disease-Modifying Antirheumatic Drugs (DMARDs): Methotrexate is first-line, others include hydroxychloroquine, sulfasalazine, leflunomide
Biological DMARDs: If poor response to traditional DMARDs, options include TNF inhibitors (e.g., etanercept, adalimumab), IL-6 inhibitors (e.g., tocilizumab), B-cell depleting agents (rituximab), T-cell costimulation blocker (abatacept)
JAK inhibitors: Such as tofacitinib, baricitinib, used when other therapies are ineffective or not tolerated
Surgical Management
Joint replacement surgery (arthroplasty): For severe joint damage, particularly in the hips and knees
Synovectomy: To reduce pain and slow disease progression in a single joint
Tenosynovectomy: To prevent tendon rupture when the tendon sheath is inflamed or damaged
Other Management
Regular follow-up: To monitor disease activity, side effects of medication, and comorbid conditions
Mental health support: To address psychological impact of living with a chronic disease
Multidisciplinary approach: Including rheumatologists, physiotherapists, occupational therapists, orthopedic surgeons, and primary care doctors
Vaccination: Against influenza and pneumococcus, given increased risk due to disease and therapy
